Accretion Pharmaceuticals Limited (NSE:ACCPL)
India · Delayed Price · Currency is INR 202.50
-9.50 (-4.48%)
At close: Nov 6, 2026
Accretion Pharmaceuticals Market Cap
Accretion Pharmaceuticals has a market cap or net worth of 2.25 billion as of November 6, 2026. It is the 35,321st most valuable company in the world and the 2,599th biggest in India. Its market cap has increased by 256.83% in one year.
Market Cap
2.25B
Enterprise Value
2.40B
Revenue
1.01B
Global Rank
Country Rank
#2,599 India
PE Ratio
17.15
ChartMarket Cap Chart
Since May 21, 2025, Accretion Pharmaceuticals's market cap has increased from 922.07M to 2.25B, an increase of 144.12%. That is a compound annual growth rate of 84.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 2.25B | 130.51% |
| Dec 31, 2025 | 976.54M | 5.91% |
| May 21, 2025 | 922.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ambalal Sarabhai Enterprises | 2.73B |
| BDH Industries | 2.46B |
| Everest Organics | 2.33B |
| Gennex Laboratories | 2.28B |
| Sanjivani Paranteral | 2.13B |
| Sat Kartar Life | 2.08B |
| Bilcare | 1.91B |
| Bio Medica Laboratories | 1.85B |